Početna stranicaIDXX • NASDAQ
add
IDEXX Laboratories, Inc.
511,78 $
Poslije radnog vremena:(0,00 %)0,00
511,78 $
Zatvoreno: 27. ruj, 20:00:00 GMT -4 · USD · NASDAQ · Odricanje od odgovornosti
Preth. zaklj. cijena
509,03 $
Dnevni raspon
509,47 $ - 518,97 $
Godišnji raspon
372,50 $ - 583,39 $
Tržišna kapitalizacija
42,12 mlr. USD
Prosječna količina
370,78 tis.
P/E omjer
50,73
Prinos dividende
-
Glavno tržište vrijednosnica
NASDAQ
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (USD) | lip 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 1,00 mlr. | 6,35 % |
Operativni troškovi | 293,86 mil. | 6,20 % |
Neto dohodak | 203,30 mil. | −9,34 % |
Neto profitabilnost | 20,26 | −14,73 % |
Zarada po dionici | 3,02 | 13,11 % |
EBITDA | 357,49 mil. | 10,34 % |
Efektivna porezna stopa | 21,52 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (USD) | lip 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 401,59 mil. | 202,32 % |
Ukupna imovina | 3,41 mlr. | 18,95 % |
Ukupne obveze | 1,83 mlr. | 3,25 % |
Ukupni kapital | 1,58 mlr. | — |
Dionice u optjecaju | 82,31 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 26,57 | — |
Povrat imovine | 24,03 % | — |
Povrat kapitala | 30,77 % | — |
Tok novca
Neto promjena novca
| (USD) | lip 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 203,30 mil. | −9,34 % |
Gotovina od poslovanja | 248,31 mil. | 23,96 % |
Gotovina iz ulaganja | −32,91 mil. | −19,79 % |
Gotovina iz financiranja | −210,24 mil. | −39,20 % |
Neto promjena novca | 4,16 mil. | −80,64 % |
Slobodan tok novca | 254,28 mil. | 48,34 % |
Više
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
Glavni izvršni direktor
Osnovano
19. pro 1983.
Web-lokacija
Zaposlenici
11.000
